Home Cart Sign in  
Chemical Structure| 846557-71-9 Chemical Structure| 846557-71-9

Structure of ML385
CAS No.: 846557-71-9

Chemical Structure| 846557-71-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML385 is an Nrf2 inhibitor that suppresses Nrf2 transcriptional activity with an IC50 value of 1.9 μM. ML385 has antioxidant and antitumor effects and is used in research on cancer and oxidative stress-related diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML385

CAS No. :846557-71-9
Formula : C29H25N3O4S
M.W : 511.59
SMILES Code : O=C(NC1=NC(C2=CC=C(N(C(C3=C(C)C=CC=C3)=O)CC4)C4=C2)=C(C)S1)CC5=CC(OCO6)=C6C=C5
MDL No. :MFCD06616124
InChI Key :LINHYWKZVCNAMQ-UHFFFAOYSA-N
Pubchem ID :1383822

Safety of ML385

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
KYSE150 cells 5 μM 48 h ML385 further elevated irradiation-induced ROS, enhancing the irradiation-mediated reduction in cell viability. PMC11538512
KYSE450 cells 5 μM 48 h Inhibition of NRF2 by ML385 caused a substantial increase in ROS levels and a significant reduction in cell viability. PMC11538512
N2A cells 5µM #VALUE! PMC9612919
BV2 cells 2µM #VALUE! PMC9612919
MDA-MB-436 cells 5 μM Inhibited Nrf2 expression, downregulated HBXIP and NQO1 protein expression. PMC8758767
MG-63 cells 2 µM 2 and 4 h ML385 significantly increased ROS production in MG-63 cells, indicating that Nrf-2 activation is closely related to and negatively regulates ROS generation. PMC5961647
Rat nucleus pulposus cells (NPCs) 5 μM To investigate the role of ML385 in inhibiting KGN-mediated antioxidant functions, results showed that ML385 suppressed the expression of antioxidant enzymes in KGN-treated NPCs and led to ECM metabolic imbalance. PMC10407629

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice KYSE150 cell xenograft model Not specified 30 mg/kg 5 times per week for 3 weeks ML385 significantly suppressed ΔNp63α-mediated tumor growth, indicating that NRF2 inhibition can counteract ΔNp63α-mediated radioresistance. PMC11538512
Mice Subarachnoid hemorrhage model Intraperitoneal injection 30 mg/kg Single injection, lasting 30 minutes ML385 blocked the Keap1/Nrf2 signaling pathway, inhibiting the antioxidant effects of EDB and EDA. PMC11169797
Mice Middle cerebral artery occlusion model Intraperitoneal injection 30 mg/kg Once daily for 7 days To evaluate the effect of ML385 on the Nrf2/HO-1 signaling pathway, ML385 treatment reversed the influence of curcumol on microglial polarization PMC11196256
BALB/c mice LPS-induced sickness behavior model Intraperitoneal injection 30 mg/kg Single injection, lasting 24 hours To evaluate the effect of ML385 on the protective effects of DMF, results showed that ML385 reversed the protective effects of DMF on LPS-induced sickness behavior. PMC8631454

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.20mL

9.77mL

1.95mL

0.98mL

19.55mL

3.91mL

1.95mL

References

 

Historical Records

Categories